Thanks to our world-class researchers, state-of-the-art technologies and unrelenting focus on scientific excellence, Merck is at the forefront of discovering and developing innovative ways to treat and prevent disease.
Scientific innovation has always been the cornerstone of our company and that continues today. Today, we conduct research in a broad range of therapeutic categories – including cardiovascular, diabetes and endocrinology, neurosciences and ophthalmology, oncology, infectious diseases, and respiratory and immunology.
To help achieve our goal of saving and improving lives around the world, we have expanded our capabilities in new areas, such as biologics and biosimilars.
The process of identifying and developing medicines is long and challenging. It begins by exploring the roots of a disease or condition. Which aspect of a disease should we target, and with what type of molecule?
If a candidate molecule proves promising, it then continues through years of rigorous testing and must obtain regulatory approval before it reaches the market. A very small fraction of the candidates that begin evaluation will ultimately survive the tough process of research, development and testing to finally become medicines.
EngageZone aims to enhance collaboration among our partners - clinical investigators, contract manufacturing organizations and clinical researchers. Our goal is to provide investigators, sponsors, researchers and contract research organization partners with a robust way to access and exchange information. The introduction of the Merck Partner Portal is an example of how Merck will continue to lead the pharmaceutical industry by becoming your Scientific Partner of Choice.Learn more
Looking for information about Merck-sponsored clinical trials? Merck posts information online about Merck-sponsored clinical trials in patients – including the results of those trials, regardless of outcome.Learn more